Published in J Adv Res on June 18, 2016
EASL Recommendations on Treatment of Hepatitis C 2015. J Hepatol (2015) 5.75
Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis (2012) 3.22
Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations. Hepatology (2012) 3.04
Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology (2007) 2.36
Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis (2009) 2.10
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med (2013) 2.02
Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet (2002) 1.92
A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clin Gastroenterol Hepatol (2009) 1.86
Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke (2010) 1.82
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Atherosclerosis (2012) 1.79
Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population. Int J Clin Pract (2013) 1.54
Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart (2004) 1.43
Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans. J Viral Hepat (2007) 1.43
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. Hepatology (2004) 1.42
Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol (2007) 1.37
Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J (2003) 1.31
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. Hepatology (2014) 1.27
The interaction of metabolic factors with HCV infection: does it matter? J Hepatol (2012) 1.22
Myocardial injury in patients with chronic hepatitis C infection. J Hepatol (2012) 1.18
No association between hepatitis C virus seropositivity and acute myocardial infarction. Clin Infect Dis (2006) 1.16
Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol (2008) 1.16
Extrahepatic manifestations of chronic hepatitis C virus infection. Dig Liver Dis (2014) 1.16
Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol (2009) 1.13
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol (2013) 1.13
Does hepatitis C virus infection increase risk for stroke? A population-based cohort study. PLoS One (2012) 1.12
Lack of any association between persistent hepatitis B or C virus infection and coronary artery disease. Atherosclerosis (2005) 1.09
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms. World J Gastroenterol (2014) 1.08
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C. Gastroenterology (2015) 1.07
Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients. J Clin Endocrinol Metab (2005) 1.06
Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system. Circ J (2008) 1.05
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Hepatology (2010) 1.02
Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study. AIDS (2009) 0.99
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies. Gastroenterology (2015) 0.99
Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen. World J Gastroenterol (2014) 0.98
Cardiovascular diseases and HCV infection: a simple association or more? Gut (2013) 0.97
Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan. Aliment Pharmacol Ther (2013) 0.96
Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors. Gut (2010) 0.95
Chronic HCV infection is a risk factor of ischemic stroke. Atherosclerosis (2013) 0.95
Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection. Atherosclerosis (2012) 0.94
Metabolic alterations and hepatitis C: From bench to bedside. World J Gastroenterol (2016) 0.91
Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity. Atherosclerosis (2003) 0.91
Carotid and femoral atherosclerosis in chronic hepatitis C: a 5-year follow-up. Angiology (2008) 0.91
Hepatitis C virus infection increases the risk of developing peripheral arterial disease: a 9-year population-based cohort study. J Hepatol (2014) 0.91
Hepatitis C virus infection in hemodialysis patients is not associated with insulin resistance, inflammation and atherosclerosis. Clin Nephrol (2009) 0.88
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J Gastroenterol (2015) 0.87
HCV infection and metabolic syndrome: which is the chicken and which is the egg? Gastroenterology (2012) 0.86
Impact of hepatitis C seropositivity on the risk of coronary heart disease events. Am J Cardiol (2014) 0.86
Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C. Clin Gastroenterol Hepatol (2012) 0.85
Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study. J Viral Hepat (2011) 0.85
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents. Clin Microbiol Infect (2016) 0.83
Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality? Dig Liver Dis (2015) 0.83
Metabolic factors and chronic hepatitis C: a complex interplay. Biomed Res Int (2013) 0.82
Association between chronic hepatitis C infection and coronary flow reserve in dialysis patients with failed renal allografts. Transplant Proc (2009) 0.82
Chronic HCV infection increases cardiac left ventricular mass index in normotensive patients. J Hepatol (2014) 0.81
Thromboembolic events among patients with hepatitis C virus infection and cirrhosis: a matched-cohort study. Adv Ther (2014) 0.80
Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure. Mem Inst Oswaldo Cruz (2014) 0.80
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin. J Hepatol (2015) 0.79
HCV 3a core protein increases lipid droplet cholesteryl ester content via a mechanism dependent on sphingolipid biosynthesis. PLoS One (2014) 0.78
Thrombin activation and liver inflammation in advanced hepatitis C virus infection. World J Gastroenterol (2016) 0.78
The impact of obesity and metabolic syndrome on chronic hepatitis C. Clin Liver Dis (2013) 0.77
Cardiovascular events in chronic hepatitis C: prognostic value of liver stiffness evolution. Eur J Gastroenterol Hepatol (2015) 0.76
Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease. Int J Cardiovasc Imaging (2015) 0.76
The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study. Drug Alcohol Depend (2015) 0.76
Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein. PLoS One (2016) 0.76